Recurrent Failures in assIsted Reproductive Techniques (The FIRST Registry)

C

Casa Sollievo della Sofferenza IRCCS

Status

Unknown

Conditions

Infertility

Study type

Observational

Funder types

Other

Identifiers

NCT02685800
FIRST - V 1_28 Ago 15

Details and patient eligibility

About

Assisted Reproductive Technologies (ARTs) are widely used in couples with fertility problems. However, despite ART treatment options have evolved over time, the implantation rate remains rather low. A possible role for inherited and acquired thrombophilias has been invoked, especially in women with previous implantation failures. However, several factors could play a role in these conditions. A potential benefit of low-molecular-weight heparin (LMWH) in improving ART outcomes, independently of the presence of thrombophilia, has been recently suggested. This register is designed in order to better define all possible variables influencing ART outcome and improve clinical management of women with previous implantation failures. During this study the investigators will collect and evaluate clinical data regarding the first cycle in women with previous ART failures.

Enrollment

624 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 2 or more implantation failures/losses of clinical pregnancies after ART
  • ART cycle at enrolment
  • Informed consent

Exclusion criteria

  • Ovarian hypofunction
  • Uterine pathology
  • Hydrosalpinges
  • Previous inclusion in the study

Trial contacts and locations

1

Loading...

Central trial contact

Elvira Grandone; Michela Villani

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems